Ivermectin 272Mcg, Pyrantel 227Mg

Verify with FDA CVM →

1,038 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,038
Total Reports
23
Deaths Reported
220.0%
Death Rate

Active Ingredients

Ivermectin 272Mcg, Pyrantel 227Mg

Administration Routes

OralUnknown

Species Affected

Dog 988
Unknown 47
Human 2
Cat 1

Most Affected Breeds

Retriever - Labrador 294
Shepherd Dog - German 99
Retriever - Golden 69
Crossbred Canine/dog 61
Unknown 49
Dog (unknown) 47
Boxer (German Boxer) 36
American Pit Bull Terrier 34
Rottweiler 33
Siberian Husky 18

Most Reported Reactions

INEFFECTIVE, HEARTWORM LARVAE 477
Lack of efficacy - NOS 200
Vomiting 142
Lack of efficacy (endoparasite) - hookworm 133
INEFFECTIVE, ASCARIDS NOS 108
Diarrhoea 75
Drug dose administration interval too long 60
Lethargy (see also Central nervous system depression in 'Neurological') 60
Drug dose omission 46
Underfilling, Package 27
Overdose 25
Uncoded sign 23

Outcome Breakdown

Outcome Unknown
637 (64.3%)
Recovered/Normal
260 (26.2%)
Recovered with Sequela
36 (3.6%)
Ongoing
35 (3.5%)
Died
15 (1.5%)
Euthanized
8 (0.8%)

Data Summary

Metric Value
Total adverse event reports 1,038
Reports involving death 23
Case-fatality rate (reported events) 220.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin 272Mcg, Pyrantel 227Mg Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 1,038 adverse event reports referencing Ivermectin 272Mcg, Pyrantel 227Mg, including 23 reports in which the animal died — a 220.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin 272Mcg, Pyrantel 227Mg. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin 272Mcg, Pyrantel 227Mg reports are Dog (988 reports), Unknown (47 reports), Human (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (294), Shepherd Dog - German (99), Retriever - Golden (69) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin 272Mcg, Pyrantel 227Mg are INEFFECTIVE, HEARTWORM LARVAE (477), Lack of efficacy - NOS (200), Vomiting (142), Lack of efficacy (endoparasite) - hookworm (133). Of the 991 reports with a coded outcome, Outcome Unknown is the leading category at 64.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin 272Mcg, Pyrantel 227Mg.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial